Contact
searchSearch
HMP Global

Biosimilars Topic Center

Featured Article

Conference Coverage
Real-World Strategies for Implementing Biosimilars
04/12/2023
Hannah Musick
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed...
04/12/2023
First Report Managed Care
From First Report Managed Care
Conference Insider
Addressing and Understanding Challenges Linked With Adopting Biosimilars Into Practice
12/08/2020
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations...
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations...
In a session at ASHP Midyear...
12/08/2020
Pharmacy Learning Network
Quiz
Identifying Pharmacist Knowledge of a Medication Drug Type
11/24/2020
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data,...
11/24/2020
Pharmacy Learning Network
News
Most Pharmacists Show Good Grasp of Biosimilar Medications, Study Finds
11/20/2020
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug...
11/20/2020
Pharmacy Learning Network
Newsfeed
Biosimilar Infliximab Appears Effective in Crohn`s Disease
12/11/2018
An infliximab biosimilar appears to be safe and effective in infliximab-naive patients with Crohn's disease, according to a recent study.
An infliximab biosimilar appears to be safe and effective in infliximab-naive patients with Crohn's disease, according to a recent study.
An infliximab biosimilar appears...
12/11/2018
Pharmacy Learning Network
News
Etanercept Biosimilar is Effective, Well-Tolerated for Rheumatoid Arthritis
02/16/2018
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the...
02/16/2018
Pharmacy Learning Network
News
Biosimilar Infliximab Appears Safe, Effective in IBD Patients
12/15/2017
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the...
12/15/2017
Pharmacy Learning Network
News
Pharmacist Role in Promoting Proper Biosimilar Usage
12/14/2017
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD,...
12/14/2017
Pharmacy Learning Network
News
FDA Approves Another Biosimilar for RA Drug
12/14/2017
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a...
12/14/2017
Pharmacy Learning Network
News
FDA Approves First Biosimilar for Breast, Stomach Cancer
12/01/2017
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a...
12/01/2017
Pharmacy Learning Network
News
The Challenges of Bringing Biosimilars to Market
11/21/2017
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a...
11/21/2017
Pharmacy Learning Network

Newsfeed

News
Communication Needed to Improve Biosimilar Transition, Adherence
10/19/2017
Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from an originator treatment to a biosimilar stopped taking the biosimilar medication within 6 months, a study showed. 
Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from an originator treatment to a biosimilar stopped taking the biosimilar medication within 6 months, a study showed. 
Patients with rheumatoid...
10/19/2017
Pharmacy Learning Network
News
FDA Approves Amgen`s Cheaper Copy of Arthritis Drug Humira
09/23/2016
The FDA has approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
The FDA has approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
The FDA has approved a cheaper,...
09/23/2016
Pharmacy Learning Network
News
Novartis Biosimilar Takes Aim at Amgen`s Enbrel
10/23/2015
The FDA has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's blockbuster anti-TNF drug Enbrel, the Swiss drugmaker said.
The FDA has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's blockbuster anti-TNF drug Enbrel, the Swiss drugmaker said.
The FDA has accepted Novartis...
10/23/2015
Pharmacy Learning Network
News
FDA Proposes Adding Suffixes to Distinguish Biosimilar Drug Names
08/28/2015
The FDA proposed on Thursday identifying cheaper versions of biologic drugs with a suffix to distinguish them from their more expensive, branded counterparts.
The FDA proposed on Thursday identifying cheaper versions of biologic drugs with a suffix to distinguish them from their more expensive, branded counterparts.
The FDA proposed on Thursday...
08/28/2015
Pharmacy Learning Network
News
RSV Vaccination Averts Thousands of Severe Outcomes in First Year of US Adult Use
09/26/2025
Hannah Musick
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus...
09/26/2025
Pharmacy Learning Network
News
FDA Announces Class II Recall of Bevacizumab Injection
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
Ascend Laboratories Recalls Aripiprazole Lot Nationwide Due to Superpotent Tablets
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall of Cyclobenzaprine Tablets Due to Label Mix-Up with Meloxicam
09/24/2025
Juliet Gallagher
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc....
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall of Zydus Succinylcholine Chloride Injection Over Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has...
09/16/2025
Pharmacy Learning Network
News
Duloxetine Capsules Recalled Over Nitrosamine Impurity
09/16/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has...
09/16/2025
Pharmacy Learning Network
News
Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued...
09/16/2025
Pharmacy Learning Network
News
KIMMTRAK (tebentafusp-tebn) Injection Recalled Due to Subpotency
09/10/2025
Hannah Musick
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been...
09/10/2025
Pharmacy Learning Network
News
Class II Recall for Multiple Strengths of Chlorpromazine Tablets Due to Contaminated Packaging Material
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Multiple DermaRite Antiseptic and Analgesic Products Due to Dangerous Microbial Contamination
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network

Insights

Interactive Features

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use